Clariant announced the completion of the sale of its healthcare packaging business to a newly-formed investment of Arsenal Capital Partners, the signing of which was announced on 22 July 2019. The sale was closed on 31 October 2019.
“The divestment of the healthcare packaging business is the first step of our announced strategy to become a more focused and innovative specialty chemical company,” said Hariolf Kottmann, executive chairman of Clariant.
The total consideration of the sale amounts to approximately $312.24mn, which is equivalent to 13.2 times adjusted 2018 EBITDA.
For the latest refining and petrochemical industry related videos, subscribe to our YouTube page.